Estimated read time: Less than a minute
This archived news story is available only for your personal, non-commercial use. Information in the story may be outdated or superseded by additional information. Reading or replaying the story in its archived form does not constitute a republication of the story.
ALBUQUERQUE, N.M. (AP) — Researchers in New Mexico plan to reach out to drug users for inclusion in a nationwide study of hepatitis C treatments.
The Albuquerque Journal reports (http://bit.ly/1ZNJEby ) that the University of New Mexico will receive $2.3 million to compare two models for treating the virus, which is often transmitted when people injecting drugs share needles.
The project is funded by the Washington D.C.-based nonprofit Patient-Centered Outcomes Research Institute. The research institute says injection drug users rarely get the most effective hepatitis C treatments.
UNM is one of eight places that will participate in the $14 million five-year study, treating an estimated 1,000 people nationally.
Hepatitis C infects up to 35,000 people in New Mexico and is the leading cause of liver transplants.
___
Information from: Albuquerque Journal, http://www.abqjournal.com
Copyright © The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
